Ebola viruses

Bio & Pharma SK Bioscience to develop 2nd-generation Ebola vaccine

South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...

Bio & Pharma Dong-A ST, UMass to jointly research for gene therapy

South Korea's Dong-A ST announced on Friday it has signed a joint research agreement with the University of Massachusetts (UMass) Chan Medical Schoo...

Bio & Pharma SK Bioscience to produce MSD’s new Ebola vaccine candidate

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a contract with MSD, a global pharma...

Bio & Pharma Celltrion teams up with bio venture to develop new anti-cancer drug

South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...

COVID-19 Celltrion says COVID-19 antibody kills virus within 5 days; shares surge

South Korea’s biopharmaceutical firm Celltrion Inc. can unveil an antibody treatment by around the end of the year that is able to kill the COVI...

Markets NPS raises virus-induced threat level to grave; runs emergency team

The National Pension Service (NPS) takes the current financial market volatility caused by the COVID-19 outbreak as a grave threat and is operating it...